4D Molecular Correlations

FDMT Stock  USD 4.54  0.02  0.44%   
The current 90-days correlation between 4D Molecular Therapeutics and Revolution Medicines is 0.31 (i.e., Weak diversification). The correlation of 4D Molecular is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

4D Molecular Correlation With Market

Significant diversification

The correlation between 4D Molecular Therapeutics and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 4D Molecular Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

Moving together with FDMT Stock

  0.66TERN Terns PharmaceuticalsPairCorr
  0.78CTMX CytomX TherapeuticsPairCorr
  0.62EMBC Embecta CorpPairCorr

Moving against FDMT Stock

  0.34GANX Gain TherapeuticsPairCorr
  0.34PHGE Biomx IncPairCorr
  0.34CGTX Cognition TherapeuticsPairCorr
  0.5OBI Ondine BiomedicalPairCorr
  0.48SSNLF Samsung ElectronicsPairCorr
  0.39EC Ecopetrol SA ADR Earnings Call TomorrowPairCorr
  0.33PTITF PT Indosat TbkPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
CGEMIPSC
CGEMCCCC
CGEMMLYS
CCCCIPSC
MLYSIPSC
IPSCRVMD
  
High negative correlations   
CGEMBCEL
MLYSBCEL
CCCCBCEL
EWTXBCEL
IPSCBCEL
PASGBCEL

Risk-Adjusted Indicators

There is a big difference between FDMT Stock performing well and 4D Molecular Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze 4D Molecular's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
TCRR  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
RVMD  1.72 (0.39) 0.00 (0.53) 0.00 
 2.10 
 14.57 
BDTX  3.54 (0.22) 0.00 (0.19) 0.00 
 5.02 
 29.04 
BCEL  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
PASG  5.70  0.03  0.00 (0.03) 5.73 
 9.86 
 84.39 
IPSC  3.23 (0.79) 0.00 (0.75) 0.00 
 6.29 
 31.00 
EWTX  2.69 (0.25) 0.00 (0.14) 0.00 
 4.81 
 26.44 
CCCC  3.58 (0.54) 0.00 (0.29) 0.00 
 8.02 
 22.96 
MLYS  3.35 (0.24) 0.00 (0.48) 0.00 
 7.79 
 26.52 
CGEM  2.48 (0.65) 0.00 (1.68) 0.00 
 4.98 
 15.27 

4D Molecular Corporate Management

FAAAAI FAAPSenior PulmonologyProfile
Christopher SimmsChief OfficerProfile
Uneek MehraChief OfficerProfile
JD EsqChief OfficerProfile
Mike ZanoniVP RelationsProfile
Noriyuki MDChief OfficerProfile